Zhengqing Yan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

PDGFRA mediates the PI3K/AKT signaling pathway to regulate the growth and phenotype of GCTB tumor cells.

PDGFRA mediates the PI3K/AKT signaling pathway to regulate the growth and phenotype of GCTB tumor cells.

Journal: International journal of clinical and experimental pathology

Published: November 14, 2025

In-vivo tissue healing mechanism at the intestinal anastomosis site following high-frequency electric welding.

In-vivo tissue healing mechanism at the intestinal anastomosis site following high-frequency electric welding.

Journal: International journal of surgery (London, England)

Published: April 19, 2024

Molecular characterization of Chinese patients with small bowel adenocarcinoma.

Molecular characterization of Chinese patients with small bowel adenocarcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 08, 2023

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.

Journal: Frontiers in oncology

Published: March 24, 2022

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy.

Journal: Frontiers in oncology

Published: December 07, 2021

Case Report: Durable Clinical Response to Third-Line Pyrotinib After Resistance to Trastuzumab in a Gastric Cancer Patient.

Case Report: Durable Clinical Response to Third-Line Pyrotinib After Resistance to Trastuzumab in a Gastric Cancer Patient.

Journal: Frontiers in oncology

Published: September 21, 2021

Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report.

Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report.

Journal: Frontiers in oncology

Published: September 17, 2021

The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy.

The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy.

Journal: Annals of translational medicine

Published: September 03, 2021

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades.

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades.

Journal: Frontiers in oncology

Published: February 09, 2021

Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations.

Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations.

Journal: OncoTargets and therapy

Published: June 21, 2020

Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication.

Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication.

Journal: Journal for immunotherapy of cancer

Published: May 11, 2020

Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report.

Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report.

Journal: OncoTargets and therapy

Published: August 26, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026